Elanco Animal Health Inc
NYSE:ELAN
Elanco Animal Health Inc
NYSE:ELAN
Price:
25.15
USD
1%
Market Cap:
$12.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
Shree Cement Ltd
NSE:SHREECEM
|
IN |
Relative Value
The Relative Value of one
ELAN
stock under the Base Case scenario is
22.93
USD.
Compared to the current market price of 25.15 USD,
Elanco Animal Health Inc
is
Overvalued by 9%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ELAN
Relative Value
Base Case
22.93
USD
Overvaluation 9%
Multiples Across Competitors
ELAN Competitors Multiples
Elanco Animal Health Inc Competitors
Elanco Animal Health Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Elanco Animal Health Inc
NYSE:ELAN
|
12.4B USD | 2.7 | -53.9 | 17.1 | 63.2 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.2 | 41.8 | 28.2 | 30.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.2 | 21.6 | 15 | 18.5 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.5 | 15.8 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.5 | 16.8 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
